First Time Loading...

Marinus Pharmaceuticals Inc
NASDAQ:MRNS

Watchlist Manager
Marinus Pharmaceuticals Inc Logo
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Watchlist
Price: 1.515 USD 2.36% Market Closed
Updated: May 7, 2024

Marinus Pharmaceuticals Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Marinus Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Revenue
$31m
CAGR 3-Years
162%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Revenue
$85.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$45.5B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$55.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$61.4B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Revenue
$35.9B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
5%

See Also

What is Marinus Pharmaceuticals Inc's Revenue?
Revenue
31m USD

Based on the financial report for Dec 31, 2023, Marinus Pharmaceuticals Inc's Revenue amounts to 31m USD.

What is Marinus Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 3Y
162%

Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Marinus Pharmaceuticals Inc have been 162% over the past three years .